M. van Puijenbroek

发表

HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression

G. Fleuren, H. Morreau, C. Cornelisse, 2007, BMC Cancer.

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

H. Morreau, M. van Engeland, T. van Wezel, 2010, BMC Cancer.

Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas

E. Jordanova, H. Morreau, T. van Wezel, 2009, BMC Cancer.

Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer

J. Houwing-Duistermaat, R. Houlston, P. Devilee, 2010, Genes, chromosomes & cancer.

Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).

A. Wagner, H. Morreau, M. Breuning, 2006, Gastroenterology.

MUTYH‐associated polyposis carcinomas frequently lose HLA class I expression—a common event amongst DNA‐repair‐deficient colorectal cancers

H. Morreau, T. van Wezel, H. Vasen, 2009, The Journal of pathology.

Identification of MEN1 and HRPT2 somatic mutations in paraffin‐embedded (sporadic) parathyroid carcinomas

M. H. Tan, B. Teh, G. Fleuren, 2007, Clinical endocrinology.

Extending the p16-Leiden tumour spectrum by respiratory tract tumours

P. Devilee, H. Meijers-Heijboer, A. V. D. van den Ouweland, 2004, Journal of Medical Genetics.

Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide

M. Kap, J. Laman, C. Schwärzler, 1998, Multiple sclerosis.

Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

A. de la Chapelle, H. Meijers-Heijboer, A. Wagner, 2003, American journal of human genetics.

Identification of Patients with (Atypical) MUTYH-Associated Polyposis by KRAS2 c.34G > T Prescreening Followed by MUTYH Hotspot Analysis in Formalin-Fixed Paraffin-Embedded Tissue

H. Morreau, T. van Wezel, M. Weiss, 2008, Clinical Cancer Research.

High frequency of copy‐neutral LOH in MUTYH‐associated polyposis carcinomas

H. Morreau, T. van Wezel, N. T. Ter Haar, 2008, The Journal of pathology.

Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.

E. Jordanova, G. Fleuren, H. Morreau, 2008, Cancer research.

Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues.

R. Vossen, H. Morreau, A. Cleton-Jansen, 2010, The Journal of molecular diagnostics : JMD.

Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype

P. Devilee, C. V. van Asperen, H. Morreau, 2005, The Journal of pathology.

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

P. Møller, H. V. van Houwelingen, G. Kenter, 2004, Gastroenterology.

Microsatellite Instability, Immunohistochemistry, and Additional PMS2 Staining in Suspected Hereditary Nonpolyposis Colorectal Cancer

H. Meijers-Heijboer, A. Wagner, H. Morreau, 2004, Clinical Cancer Research.

Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma

G. Fleuren, M. Karperien, C. Haven, 2004, The Journal of pathology.

Gene Expression of Parathyroid Tumors

P. Eilers, K. Furge, B. Teh, 2004, Cancer Research.

The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC.

P. Eilers, H. Morreau, J. Kleibeuker, 2004, Gastroenterology.

High-resolution analysis of HLA class I alterations in colorectal cancer

Hans Morreau, C. V. D. van de Velde, H. Morreau, 2006, BMC Cancer.

Molecular Analysis of Colorectal Cancer Tumors from Patients with Mismatch Repair–Proficient Hereditary Nonpolyposis Colorectal Cancer Suggests Novel Carcinogenic Pathways

H. Morreau, T. Caldés, M. de la Hoya, 2007, Clinical Cancer Research.

Correspondence re: A. Müller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res., 62: 1014-1019, 2002.

R. Tollenaar, H. Morreau, C. Cornelisse, 2003, Cancer research.

Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).

H. Morreau, N. Gruis, W. Bergman, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Identification of HNPCC by Molecular Analysis of Colorectal and Endometrial Tumors

H. Morreau, H. Vasen, A. Bröcker-Vriends, 2004, Disease markers.

Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.

H. Morreau, A. Cleton-Jansen, T. van Wezel, 2005, The Journal of molecular diagnostics : JMD.

Duodenal carcinoma in MUTYH-associated polyposis

E. Kuipers, S. Verhoef, A. Wagner, 2006, Journal of Clinical Pathology.

Increased frequency of 20q gain and copy‐neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas

H. Morreau, T. van Wezel, T. Caldés, 2012, International journal of cancer.

Identification of Patients with (Atypical) MUTYH-Associated Polyposis by KRAS2 c.34G > T Prescreening Followed by MUTYH Hotspot Analysis in Formalin-Fixed Paraffin-Embedded Tissue

H. Morreau, T. van Wezel, M. Weiss, 2008, Clinical Cancer Research.